159 related articles for article (PubMed ID: 30766562)
21. Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3.
Di Gioia D; Blankenburg I; Nagel D; Heinemann V; Stieber P
Clin Chim Acta; 2016 Oct; 461():1-7. PubMed ID: 27451906
[TBL] [Abstract][Full Text] [Related]
22. Serum CA 125, CA 15-3, CEA, and CA 19-9: a prognostic factor for uterine carcinosarcomas?
Thomakos N; Rodolakis A; Zagouri F; Zacharakis D; Sotiropoulou M; Akrivos N; Haidopoulos D; Papadimitriou CA; Dimopoulos MA; Antsaklis A
Arch Gynecol Obstet; 2013 Jan; 287(1):97-102. PubMed ID: 22941327
[TBL] [Abstract][Full Text] [Related]
23. The value of standard serum tumor markers in differentiating mucinous from serous cystic tumors of the pancreas: CEA, Ca 19-9, Ca 125, Ca 15-3.
Bassi C; Salvia R; Gumbs AA; Butturini G; Falconi M; Pederzoli P
Langenbecks Arch Surg; 2002 Nov; 387(7-8):281-5. PubMed ID: 12447553
[TBL] [Abstract][Full Text] [Related]
24. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
[TBL] [Abstract][Full Text] [Related]
25. Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer.
Wang G; Qin Y; Zhang J; Zhao J; Liang Y; Zhang Z; Qin M; Sun Y
Int J Mol Sci; 2014 May; 15(6):9546-65. PubMed ID: 24879526
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of cancer antigen, CA 15.3 in breast cancer.
Muthuswamy S; Raste AS
Indian J Med Sci; 2000 Oct; 54(10):442-7. PubMed ID: 11262861
[TBL] [Abstract][Full Text] [Related]
27. The value of serum CA 125 and association CA 125/CA 19-9 in endometrial carcinoma.
Cherchi PL; Dessole S; Ruiu GA; Ambrosini G; Farina M; Capobianco G; Ambrosini A
Eur J Gynaecol Oncol; 1999; 20(4):315-7. PubMed ID: 10475131
[TBL] [Abstract][Full Text] [Related]
28. Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
Imamura M; Morimoto T; Nomura T; Michishita S; Nishimukai A; Higuchi T; Fujimoto Y; Miyagawa Y; Kira A; Murase K; Araki K; Takatsuka Y; Oh K; Masai Y; Akazawa K; Miyoshi Y
World J Surg Oncol; 2018 Feb; 16(1):26. PubMed ID: 29433529
[TBL] [Abstract][Full Text] [Related]
29. Is parathyroid hormone-related protein a sensitive serum marker in advanced breast cancer?
Pyke CM; Menezes G; Purdie DM; Johnson S; Cowley D
Aust N Z J Surg; 1997 May; 67(5):256-9. PubMed ID: 9152154
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of CEA, CA 125, and CA 15-3 serum tumour markers in different regions of Saudi Arabia.
Ashi A; Al-Hajeili M; Almaghrabi S; Al-Maghrabi J; Trabulsi N; Alghuraibi S; Alsiary R; Alrayes N
Saudi Med J; 2024 Jun; 45(6):565-571. PubMed ID: 38830664
[TBL] [Abstract][Full Text] [Related]
31. Menstrual cycle dependent variability for serum tumor markers CEA, AFP, CA 19-9, CA 125 and CA 15-3 in healthy women.
Erbağci AB; Yilmaz N; Kutlar I
Dis Markers; 1999 Dec; 15(4):259-67. PubMed ID: 10689549
[TBL] [Abstract][Full Text] [Related]
32. The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules.
Bekci TT; Senol T; Maden E
J Int Med Res; 2009; 37(2):438-45. PubMed ID: 19383238
[TBL] [Abstract][Full Text] [Related]
33. Predictive power of sexual hormones and tumor markers in endometrial cancer.
Kanat-Pektas M; Yenicesu O; Gungor T; Bilge U
Arch Gynecol Obstet; 2010 Apr; 281(4):709-15. PubMed ID: 19777250
[TBL] [Abstract][Full Text] [Related]
34. Endometrial ablation in the management of abnormal uterine bleeding.
Laberge P; Leyland N; Murji A; Fortin C; Martyn P; Vilos G; ; Leyland N; Wolfman W; Allaire C; Awadalla A; Dunn S; Heywood M; Lemyre M; Marcoux V; Potestio F; Rittenberg D; Singh S; Yeung G;
J Obstet Gynaecol Can; 2015 Apr; 37(4):362-79. PubMed ID: 26001691
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic Impacts of Serum CA-125 Levels, Pap Smear Evaluation, and Endometrial Sampling in Women with Endometrial Clear Cell Carcinoma.
Cetinkaya N; Selcuk İ; Ozdal B; Meydanli MM; Gungor T
Oncol Res Treat; 2016; 39(5):283-8. PubMed ID: 27173475
[TBL] [Abstract][Full Text] [Related]
36. [Value of ER, VIM, CEA and p16 detection in the diagnosis and differential diagnosis of primary endocervical and endometrial adenocarcinomas].
Hu WW; Tao JH; Li GM; Xu X; Yang XM
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):526-8, 531. PubMed ID: 20335127
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.
Bozkurt M; Yumru AE; Aral I
Eur J Gynaecol Oncol; 2013; 34(6):540-4. PubMed ID: 24601047
[TBL] [Abstract][Full Text] [Related]
38. Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer.
Bian J; Sun X; Li B; Ming L
Technol Cancer Res Treat; 2017 Aug; 16(4):435-439. PubMed ID: 27562869
[TBL] [Abstract][Full Text] [Related]
39. Are neutrophil/lymphocyte and platelet/lymphocyte ratios associated with endometrial precancerous and cancerous lesions in patients with abnormal uterine bleeding?
Acmaz G; Aksoy H; Unal D; Ozyurt S; Cingillioglu B; Aksoy U; Muderris I
Asian Pac J Cancer Prev; 2014; 15(4):1689-92. PubMed ID: 24641391
[TBL] [Abstract][Full Text] [Related]
40. [Usefulness of CEA, CA 15-3 and CA 125 tumor markers in the differential diagnostics of peritoneal effusion].
Kiluk MS; Rółkowski R; Zawadzki RJ; Wojtukiewicz MZ
Pol Merkur Lekarski; 2002 Oct; 13(76):298-301. PubMed ID: 12557435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
